Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/LABT/Capital expenditures

Lakewood-Amedex Biotherapeutics Inc. (LABT) Capital expenditures

Lakewood-Amedex Biotherapeutics Inc. (LABT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$1,846FY2024
24
Fiscal yearValueYoY
FY2024$1,846—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More LABT financial trends

LABT RevenueLABT Net incomeLABT Net marginLABT Gross profitLABT Gross marginLABT Operating incomeLABT Operating marginLABT Operating cash flowLABT Free cash flowLABT Return on equityLABT Stock buybacksLABT Dividends paidLABT Total assetsLABT Total liabilitiesLABT Shareholders’ equityLABT overview →